Kidney international. Supplement

Keyphrases

Publications

number 117, 2011

Neal Mittman, Brinda Desiraju, Kevin B Meyer, Jyoti Chattopadhyay, Morrell M Avram
Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study. Kidney international. Supplement (117) (2011)
Morrell M Avram
Symposium proceedings. Perspective: irreversible progressive chronic kidney disease -- an overview. Kidney international. Supplement (117) (2011)
Neal Mittman, Brinda Desiraju, Irfan Fazil, Hiteshkumar Kapupara, Jyoti Chattopadhyay, Chinu M Jani, Morrell M Avram
Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney international. Supplement (117) (2011)
Kamyar Kalantar-Zadeh, Anuja Shah, Uyen Duong, Rulin C Hechter, Ramanath Dukkipati, Csaba P Kovesdy
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney international. Supplement (117) (2011)
Morrell M Avram, Paul A Fein, Cezary Borawski, Jyotiprakas Chattopadhyay, Betty Matza
Extracellular mass/body cell mass ratio is an independent predictor of survival in peritoneal dialysis patients. Kidney international. Supplement (117) (2011)
Steven Fishbane, Allen R Nissenson
Anemia management in chronic kidney disease. Kidney international. Supplement (117) (2011)
Eli A Friedman
Stressful ethical issues in uremia therapy. Kidney international. Supplement (117) (2011)

number 119, 2011

Mohamed H Sayegh
Chronic renal allograft dysfunction (CAD): new frontiers. Introduction. Kidney international. Supplement (119) (2011)
Robert B Colvin, Tsutomu Hirohashi, Alton B Farris, Francesca Minnei, A Bernard Collins, R Neal Smith
Emerging role of B cells in chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Lorraine C Racusen, Heinz Regele
The pathology of chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Peter J Dupont, Oriol Manuel, Manuel Pascual
Infection and chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Soo Bong Lee, Raghu Kalluri
Mechanistic connection between inflammation and fibrosis. Kidney international. Supplement (119) (2011)
Marc-Olivier Timsit, Xiaodong Yuan, Bernhard Floerchinger, Xupeng Ge, Stefan G Tullius
Consequences of transplant quality on chronic allograft nephropathy. Kidney international. Supplement (119) (2011)
Timothy M Millington, Joren C Madsen
Innate immunity and cardiac allograft rejection. Kidney international. Supplement (119) (2011)
Paolo Cravedi, Norberto Perico, Giuseppe Remuzzi
Non-immune interventions to protect kidney allografts in the long term. Kidney international. Supplement (119) (2011)
Josep M Grinyó, Oriol Bestard, Joan Torras, Josep M Cruzado
Optimal immunosuppression to prevent chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Johan W de Fijter
Rejection and function and chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Esteban Porrini, Patricia Delgado, Armando Torres
Metabolic syndrome, insulin resistance, and chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Niloufar Safinia, Behdad Afzali, Kerem Atalar, Giovanna Lombardi, Robert I Lechler
T-cell alloimmunity and chronic allograft dysfunction. Kidney international. Supplement (119) (2011)
Enver Akalin, Philip J O'Connell
Genomics of chronic allograft injury. Kidney international. Supplement (119) (2011)
Roslyn B Mannon
Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney international. Supplement (119) (2011)

number 120, 2011

Joaquim Calado, René Santer, José Rueff
Effect of kidney disease on glucose handling (including genetic defects). Kidney international. Supplement (120) (2011)
Masayuki Isaji
SGLT2 inhibitors: molecular design and potential differences in effect. Kidney international. Supplement (120) (2011)
Amanda Mather, Carol Pollock
Glucose handling by the kidney. Kidney international. Supplement (120) (2011)
Peter Rossing, Dick de Zeeuw
Need for better diabetes treatment for improved renal outcome. Kidney international. Supplement (120) (2011)
James F List, Jean M Whaley
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans. Kidney international. Supplement (120) (2011)

number 121, 2011

Eduardo Slatopolsky, Sharon Moe
50 years of research and discovery in chronic kidney disease and mineral & bone disorder: the central role of phosphate. Kidney international. Supplement (121) (2011)
Harald Jüppner
Phosphate and FGF-23. Kidney international. Supplement (121) (2011)
Eduardo Slatopolsky
The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney international. Supplement (121) (2011)
Keith Hruska, Suresh Mathew, Richard Lund, Yifu Fang, Toshifumi Sugatani
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney international. Supplement (121) (2011)
Cyrille B Confavreux
Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney international. Supplement (121) (2011)
Makoto Kuro-O
Phosphate and Klotho. Kidney international. Supplement (121) (2011)

number 114, 2010

Helen Vlassara, Massimo Torreggiani, James B Post, Feng Zheng, Jaime Uribarri, Gary E Striker
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging. Kidney international. Supplement (114) (2010)
Phyllis P Sun, Mary C Perianayagam, Bertrand L Jaber
Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney international. Supplement (114) (2010)
Gary E Striker
Beyond phosphate binding: the effect of binder therapy on novel biomarkers may have clinical implications for the management of chronic kidney disease patients. Kidney international. Supplement (114) (2010)
Pieter Evenepoel, Bjorn K I Meijers, Bert R M Bammens, Kristin Verbeke
Uremic toxins originating from colonic microbial metabolism. Kidney international. Supplement (114) (2010)
Vincent M Brandenburg, Willi Jahnen-Dechent, Markus Ketteler
Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation. Kidney international. Supplement (114) (2010)
Sarah Seiler, Gunnar H Heine, Danilo Fliser
Clinical relevance of FGF-23 in chronic kidney disease. Kidney international. Supplement (114) (2010)

number 115, 2010

Danielle A Diarra, Markus Riegersperger, Marcus D Säemann, Gere Sunder-Plassmann
Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: a single center analysis. Kidney international. Supplement (115) (2010)
Stefan Vítko, Marek Ferkl
Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial. Kidney international. Supplement (115) (2010)
Uwe Christians, Jelena Klawitter, Claudia F Clavijo
Bioequivalence testing of immunosuppressants: concepts and misconceptions. Kidney international. Supplement (115) (2010)

number 116, 2010

George L Bakris
Overview of the KEEP international articles. Kidney international. Supplement (116) (2010)
Gregorio T Obrador, Guillermo García-García, Antonio R Villa, Ximena Rubilar, Nadia Olvera, Evangelina Ferreira, Margarita Virgen, José Alfonso Gutiérrez-Padilla, Melissa Plascencia-Alonso, Martha Mendoza-García, Salvador Plascencia-Pérez
Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney international. Supplement (116) (2010)
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai
The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period. Kidney international. Supplement (116) (2010)
Timothy H Mathew, Olivia Corso, Marie Ludlow, Adam Boyle, Alan Cass, Steven J Chadban, Beres Joyner, Mark Shephard, Tim Usherwood
Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney international. Supplement (116) (2010)

number 118, 2010

Arjang Djamali, Carolynn E Pietrangeli, Robert D Gordon, Christophe Legendre
Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile. Kidney international. Supplement (118) (2010)
James B Young, Hans-Hellmut Neumayer, Robert D Gordon
Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk. Kidney international. Supplement (118) (2010)
David Goldsmith, Carolynn E Pietrangeli
The metabolic syndrome following kidney transplantation. Kidney international. Supplement (118) (2010)